School of Biomedical Engineering and Technology, Tianjin Medical University, Tianjin 300070, China.
College of Pharmacy, Southern Medical University, Guangzhou 510280, China.
Molecules. 2024 Feb 21;29(5):932. doi: 10.3390/molecules29050932.
Non-viral vectors have been developing in gene delivery due to their safety and low immunogenicity. But their transfection effect is usually very low, thus limiting the application. Hence, we designed eight peptides (compounds -). We compared their performances; compound had the best transfection efficacy and biocompatibility. The transfection effect was similar with that of PEI, a most-widely-employed commercial transfection reagent. Atomic force microscope (AFM) images showed that the compound could self-assemble and the self-assembled peptide might encapsulate DNA. Based on these results, we further analyzed the inhibitory result in cancer cells and found that compound could partially fight against Hela cells. Therefore, the compound is promising to pave the way for the development of more effective and less toxic transfection vectors.
非病毒载体由于其安全性和低免疫原性在基因传递中得到了发展。但其转染效果通常很低,因此限制了其应用。因此,我们设计了 8 种肽(化合物 -)。我们比较了它们的性能;化合物具有最佳的转染效果和生物相容性。转染效果与最广泛使用的商业转染试剂 PEI 相似。原子力显微镜 (AFM) 图像显示,该化合物可以自组装,自组装的肽可能会包裹 DNA。基于这些结果,我们进一步分析了化合物在癌细胞中的抑制效果,发现化合物可以部分对抗 Hela 细胞。因此,该化合物有望为开发更有效、毒性更低的转染载体铺平道路。